Katrina Pedersen

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Katrina Pedersen

Oct 22, 2023, 18:11 | Insight

Katrina Pedersen: Not many people realize that there is NO prospective interventional trial data for FOLFIRI or for a powered Taxane cohort in Small Bowel Adenocarcinoma

Katrina Pedersen, Gastrointestinal Oncologist at Siteman Cancer Center, shared a post by SWOG Cancer Research…

Oct 12, 2023, 01:07 | Opinion

Katrina Pedersen: P.S. Calling a trial “First-In-Man” will earn autorejection.

Katrina Pedersen, Gastrointestinal Oncologist at Siteman Cancer Center, shared on X/Twitter: "Dear MedTwitter, I have…

Aug 27, 2023, 17:51 | Insight

Katrina Pedersen: I LOVE it when trials are stopped early due to superior benefit.

Katrina Pedersen, an Associate Professor at the Department of Medicine, Oncology Division at Washington University…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023